Immunology is an area of growth for Sanofi Genzyme and an area in which we hope to make a significant difference in patients’ lives. In collaboration with Regeneron, we are researching and developing two new therapies.
The first therapy under review with the U.S. FDA is for the treatment of adults with moderate to severe rheumatoid arthritis, a chronic and painful inflammatory disorder that damages the joints. The second, also under review with the U.S. FDA is a new therapy under investigation for adults with moderate to severe atopic dermatitis, an autoimmune disorder affecting the skin.
We are also studying other allergic and respiratory diseases, including asthma and nasal polyposis.
Last Updated: 11/10/2016